American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$342M |
| 2 |
Roper Technologies
ROP
|
+$333M |
| 3 |
Clarivate
CLVT
|
+$237M |
| 4 |
BDXB
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6.00% Mandatory Convertible Preferred Stock, Series B
BDXB
|
+$212M |
| 5 |
Medtronic
MDT
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$416M |
| 2 |
Visa
V
|
+$337M |
| 3 |
Chubb
CB
|
+$215M |
| 4 |
Starbucks
SBUX
|
+$214M |
| 5 |
Huazhu Hotels Group
HTHT
|
+$198M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.9% |
| 2 | Financials | 13.74% |
| 3 | Healthcare | 13.7% |
| 4 | Consumer Discretionary | 13.19% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Yelp
YELP
$1.32B
| $877K | ﹤0.01% |
24,204
| – | – |
|
|
GTM
1702
ZoomInfo Technologies
GTM
$1.25B
| $871K | ﹤0.01% |
+13,573
| New | +$909K |
|
|
ONC
1703
BeOne Medicines Ltd
ONC
$40.3B
| $868K | ﹤0.01% |
3,204
| – | – |
|
|
FISV
1704
Fiserv Inc
FISV
$29.5B
| $867K | ﹤0.01% |
8,357
+1,079
| +15% | +$112K |
|
1705
Dentsply Sirona
XRAY
$2.31B
| $867K | ﹤0.01% |
15,539
-320
| -2% | -$17.6K |
|
1706
Credicorp
BAP
$29.8B
| $866K | ﹤0.01% |
7,091
+1,385
| +24% | +$170K |
|
1707
Vanda Pharmaceuticals
VNDA
$304M
| $865K | ﹤0.01% |
55,104
| – | – |
|
1708
Village Super Market
VLGEA
$638M
| $864K | ﹤0.01% |
36,927
+9,443
| +34% | +$211K |
|
1709
Assurant
AIZ
$13.9B
| $863K | ﹤0.01% |
5,541
+809
| +17% | +$128K |
|
1710
Grupo Aeroportuario del Pacifico
PAC
$12.4B
| $863K | ﹤0.01% |
6,276
+3,541
| +129% | +$453K |
|
1711
Ingersoll Rand
IR
$32.7B
| $862K | ﹤0.01% |
13,926
+2,792
| +25% | +$159K |
|
1712
Arrowhead Research
ARWR
$12.1B
| $861K | ﹤0.01% |
12,986
+1,474
| +13% | +$101K |
|
1713
RB Global
RBA
$16B
| $859K | ﹤0.01% |
14,042
+9,807
| +232% | +$656K |
|
1714
Progress Software
PRGS
$1.83B
| $858K | ﹤0.01% |
17,770
| – | – |
|
1715
Amalgamated Financial
AMAL
$1.53B
| $857K | ﹤0.01% |
51,102
+13,306
| +35% | +$232K |
|
1716
ITT
ITT
$19.4B
| $856K | ﹤0.01% |
8,375
+404
| +5% | +$39.5K |
|
1717
PetMed Express
PETS
$43.4M
| $856K | ﹤0.01% |
33,892
+19,810
| +141% | +$548K |
|
1718
StoneX
SNEX
$8.05B
| $856K | ﹤0.01% |
70,723
+9,634
| +16% | +$126K |
|
1719
W.R. Berkley
WRB
$26.2B
| $856K | ﹤0.01% |
23,384
-7,169
| -23% | -$254K |
|
1720
Bio-Rad Laboratories Class A
BIO
$9.66B
| $852K | ﹤0.01% |
1,128
+289
| +34% | +$216K |
|
1721
Rapid7
RPD
$929M
| $852K | ﹤0.01% |
7,240
+161
| +2% | +$19.9K |
|
1722
C.H. Robinson
CHRW
$17.5B
| $850K | ﹤0.01% |
7,902
+785
| +11% | +$76.2K |
|
1723
Alaska Air
ALK
$5.3B
| $847K | ﹤0.01% |
16,249
-232,670
| -93% | -$12.6M |
|
1724
Sensient Technologies
SXT
$5.53B
| $847K | ﹤0.01% |
8,463
-1,267
| -13% | -$123K |
|
1725
Takeda Pharmaceutical
TAK
$55.5B
| $843K | ﹤0.01% |
61,839
+4,945
| +9% | +$69.4K |
|
Similar funds
American Century Companies's Q4 2021 Portfolio in Review
As of Q4 2021, American Century Companies held 2,425 positions worth $158B, up 7.9% from $146B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q4 2021 filing shows 131 new, 1,448 increased, 577 reduced and 118 closed positions. Its largest new stake was Clarivate: 10,217,212 shares worth $240M. The largest sale was PayPal, an estimated $416M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2021 buy was Clarivate: 10,217,212 shares worth $240M.
- American Century Companies added most to Humana in Q4 2021, an estimated $342M increase.
- American Century Companies's biggest Q4 2021 reduction was PayPal, cutting an estimated $416M.
- American Century Companies fully exited Kansas City Southern in Q4 2021, selling an estimated $114M.
- American Century Companies's ten largest holdings make up 23% of its $158B portfolio in Q4 2021.
- American Century Companies opened 131 new positions and closed 118 in Q4 2021.
- American Century Companies's portfolio value rose 7.9% quarter-over-quarter to $158B.
Based on American Century Companies's 13F filing for Q4 2021, filed 7 Feb 2022.